Stacy Hwang, PHARMD
Oncology · Santa Clara
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Stacy Hwang’s office at (408) 851-3921 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$132,394
Pharmacies billed $132,394 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 669) in 2024. At or below the middle of the specialty; the typical pharmacist clinician is at 0%.
279 generic and 285 brand-name prescriptions · $132,394 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 84 | $62,136 | $740 |
| Jardiance | 18 | $9,427 | $524 |
| Humulin N | 52 | $8,863 | $170 |
| Humulin 70/30 Kwikpen | 24 | $7,733 | $322 |
| Humulin 70-30 | 16 | $3,738 | $234 |
See all 17 drugs
| Ozempic | 84 | $62,136 | $740 |
| Jardiance | 18 | $9,427 | $524 |
| Humulin N | 52 | $8,863 | $170 |
| Humulin 70/30 Kwikpen | 24 | $7,733 | $322 |
| Humulin 70-30 | 16 | $3,738 | $234 |
| Insulin Glargine-Yfgn | 26 | $3,318 | $128 |
| Humulin R | 16 | $2,849 | $178 |
| Humulin N Kwikpen | 24 | $2,822 | $118 |
| Ultra-Fine Nano Pen Needle | 49 | $1,246 | $25 |
| Glipizide | 79 | $883 | $11 |
| Veo Insulin | 29 | $634 | $22 |
| Atorvastatin | 43 | $598 | $14 |
| Metformin | 44 | $535 | $12 |
| Metformin Hcl Er | 46 | $462 | $10 |
| Veo Insulin | 14 | $375 | $27 |
| Glipizide Er | 11 | $359 | $33 |
| Amlodipine Besylate | 12 | $153 | $13 |
Year by year
| 2024 | 669 | 138 | 0% (0) | 43% | $132,394 |
| 2023 | 608 | 120 | 0% (0) | 40% | $132,154 |
| 2022 | 595 | 117 | 0% (0) | 34% | $102,614 |
| 2021 | 437 | 111 | 0% (0) | 34% | $76,865 |
| 2020 | 482 | 143 | 0% (0) | 35% | $68,276 |
| 2019 | 944 | 201 | 0% (0) | 37% | $145,541 |
| 2018 | 907 | 192 | 0% (0) | 44% | $125,297 |
| 2017 | 855 | 160 | 0% (0) | 42% | $99,190 |
| 2016 | 597 | 129 | 0% (0) | 49% | $72,887 |
| 2015 | 136 | 55 | 0% (0) | 41% | $12,897 |
| 2014 | 71 | 31 | 0% (0) | 25% | $3,223 |
| 2013 | 137 | 52 | 0% (0) | 38% | $14,415 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Ozempic | 32 | $28,560 | $892 |
| Jardiance | 21 | $13,211 | $629 |
| Humulin N | 58 | $9,622 | $166 |
| Humulin 70-30 | 30 | $8,733 | $291 |
| Humulin 70/30 Kwikpen | 19 | $7,002 | $369 |
| Humalog Kwikpen U-100 | 11 | $5,009 | $455 |
| Humulin R | 15 | $2,503 | $167 |
| Humulin N Kwikpen | 19 | $2,155 | $113 |
| Glipizide | 77 | $919 | $12 |
| Ultra-Fine Nano Pen Needle | 33 | $904 | $27 |
| Veo Insulin | 36 | $713 | $20 |
| Atorvastatin | 34 | $685 | $20 |
| Veo Insulin | 26 | $663 | $26 |
| Metformin | 34 | $461 | $14 |
| Metformin Hcl Er | 42 | $442 | $11 |
| Pioglitazone | 16 | $306 | $19 |
| Amlodipine Besylate | 14 | $190 | $14 |
2022: 12 drugs
| Humulin N | 64 | $11,724 | $183 |
| Humulin 70-30 | 32 | $9,488 | $296 |
| Jardiance | 12 | $7,011 | $584 |
| Humulin R | 33 | $6,453 | $196 |
| Ultra-Fine Nano Pen Needle | 31 | $1,057 | $34 |
| Veo Insulin | 50 | $953 | $19 |
| Glipizide | 78 | $928 | $12 |
| Veo Insulin | 31 | $759 | $24 |
| Atorvastatin | 41 | $656 | $16 |
| Metformin Hcl Er | 51 | $529 | $10 |
| Metformin | 33 | $415 | $13 |
| Pioglitazone | 12 | $212 | $18 |
2021: 12 drugs
| Humulin N | 51 | $10,232 | $201 |
| Humulin 70-30 | 24 | $5,832 | $243 |
| Humulin R | 11 | $2,913 | $265 |
| Humulin N Kwikpen | 14 | $2,529 | $181 |
| Veo Insulin | 36 | $667 | $19 |
| Glipizide | 52 | $630 | $12 |
| Atorvastatin | 40 | $597 | $15 |
| Veo Insulin | 26 | $548 | $21 |
| Ultra-Fine Nano Pen Needle | 17 | $529 | $31 |
| Metformin Hcl Er | 32 | $319 | $10 |
| Metformin | 20 | $250 | $12 |
| Glimepiride | 11 | $148 | $13 |
2020: 13 drugs
| Humulin N | 62 | $13,076 | $211 |
| Humulin 70-30 | 34 | $8,806 | $259 |
| Humulin 70/30 Kwikpen | 11 | $5,121 | $466 |
| Humulin R | 24 | $4,650 | $194 |
| Veo Insulin | 49 | $806 | $16 |
| Atorvastatin | 47 | $779 | $17 |
| Veo Insulin | 31 | $656 | $21 |
| Ultra-Fine Short Pen Needle | 15 | $475 | $32 |
| Glipizide | 35 | $401 | $11 |
| Ultra-Fine Nano Pen Needle | 12 | $380 | $32 |
| Metformin Hcl Er | 33 | $337 | $10 |
| Metformin | 28 | $313 | $11 |
| Lisinopril | 12 | $140 | $12 |
2019: 21 drugs
| Humulin R U-500 Kwikpen | 15 | $49,749 | $3,317 |
| Humulin N | 136 | $24,926 | $183 |
| Humulin 70-30 | 79 | $22,539 | $285 |
| Lantus | 14 | $9,077 | $648 |
| Humulin 70/30 Kwikpen | 21 | $8,845 | $421 |
| Humulin R | 43 | $8,312 | $193 |
| Humalog | 18 | $5,573 | $310 |
| Humulin N Kwikpen | 12 | $2,061 | $172 |
| Veo Insulin | 111 | $1,868 | $17 |
| Atorvastatin | 65 | $1,571 | $24 |
| Glipizide | 91 | $1,116 | $12 |
| Veo Insulin | 52 | $1,045 | $20 |
| Metformin Hcl Er | 70 | $700 | $10 |
| Ultra-Fine Nano Pen Needle | 20 | $680 | $34 |
| Ultra-Fine Short Pen Needle | 19 | $649 | $34 |
| Metformin | 39 | $445 | $11 |
| Glimepiride | 18 | $241 | $13 |
| Lisinopril | 19 | $222 | $12 |
| Simvastatin | 19 | $222 | $12 |
| Amlodipine Besylate | 12 | $140 | $12 |
| Losartan | 11 | $108 | $10 |
2018: 17 drugs
| Humulin 70-30 | 101 | $29,176 | $289 |
| Humulin N | 131 | $22,815 | $174 |
| Humulin 70/30 Kwikpen | 21 | $9,706 | $462 |
| Humulin R | 40 | $8,346 | $209 |
| Lantus | 13 | $6,899 | $531 |
| Humalog | 12 | $3,702 | $309 |
| Humulin N Kwikpen | 17 | $2,311 | $136 |
| Veo Insulin | 111 | $1,905 | $17 |
| Atorvastatin | 50 | $1,465 | $29 |
| Glipizide | 87 | $1,285 | $15 |
| Veo Insulin | 48 | $1,014 | $21 |
| Metformin Hcl Er | 61 | $796 | $13 |
| Ultra-Fine Short Pen Needle | 20 | $712 | $36 |
| Metformin | 51 | $575 | $11 |
| Glimepiride | 20 | $280 | $14 |
| Lisinopril | 16 | $200 | $13 |
| Simvastatin | 18 | $200 | $11 |
2017: 15 drugs
| Humulin 70-30 | 84 | $19,983 | $238 |
| Humulin N | 122 | $19,829 | $163 |
| Humulin R | 45 | $8,965 | $199 |
| Humulin 70/30 Kwikpen | 15 | $5,607 | $374 |
| Humalog | 14 | $2,905 | $208 |
| Insulin | 127 | $2,597 | $20 |
| Atorvastatin | 50 | $1,584 | $32 |
| Glipizide | 99 | $1,515 | $15 |
| Insulin | 48 | $1,204 | $25 |
| Metformin Hcl Er | 59 | $914 | $15 |
| Ultra-Fine Short Pen Needle | 13 | $533 | $41 |
| Metformin | 37 | $428 | $12 |
| Glimepiride | 16 | $240 | $15 |
| Simvastatin | 14 | $180 | $13 |
| Lisinopril | 13 | $158 | $12 |
2016: 15 drugs
| Lantus | 17 | $11,370 | $669 |
| Humulin 70-30 | 62 | $11,242 | $181 |
| Humulin N | 91 | $10,724 | $118 |
| Humulin R | 45 | $5,653 | $126 |
| Humalog | 26 | $5,210 | $200 |
| Humulin 70/30 Kwikpen | 14 | $4,194 | $300 |
| Insulin | 95 | $2,210 | $23 |
| Glipizide | 54 | $775 | $14 |
| Insulin | 30 | $698 | $23 |
| Atorvastatin | 19 | $644 | $34 |
| Bd Ultra-Fine Pen Needle | 12 | $487 | $41 |
| Metformin Hcl Er | 27 | $378 | $14 |
| Metformin | 25 | $288 | $12 |
| Pioglitazone | 11 | $285 | $26 |
| Glimepiride | 12 | $160 | $13 |
2015: 5 drugs
| Humulin 70-30 | 16 | $2,301 | $144 |
| Insulin | 34 | $1,533 | $45 |
| Humulin N | 15 | $1,500 | $100 |
| Humulin R | 12 | $1,165 | $97 |
| Glipizide | 11 | $145 | $13 |
2014: 1 drug
| Insulin | 18 | $576 | $32 |
2013: 5 drugs
| Humulin N | 25 | $2,384 | $95 |
| Insulin | 23 | $993 | $43 |
| Insulin | 13 | $774 | $60 |
| Insulin | 11 | $536 | $49 |
| Metformin | 12 | $140 | $12 |
Professional record
- NPI
- 1417018896
- Licence
- CA RPH57695
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 1835X0200X (1835X0200X)
- Mailing address
- 770 E Calaveras Blvd, Milpitas, CA, 95035
- NPI first listed
- 2006-12-12
- NPI last updated
- 2021-12-01
- NPI record certified
- 2021-12-01
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.